CONSORTIUM

The X-PAND consortium is coordinated by Luigi Naldini, director of the San Raffaele-Telethon Institute for Gene Therapy in Milan (SR-Tiget) and by Bernhard Gentner, Associate Professor at the University of Lausanne and group leader at SR-Tiget. The other international partners of the consortium are the University of Navarra (Pamplona, Spain), the University Hospital Freiburg (Germany), The energy, environmental and technological research centre of Moncloa (Madrid, Spain), the Public Foundation Miguel Servet (Pamplona, Spain) and the Lausanne University Hospital (Switzerland).

Ospedale San Raffaele

Milan, Italy

Coordinator

Ospedale San Raffaele is a private university and research hospital and one of the leading private scientific research institutes in Italy performing cutting-edge science with the aim to advance the knowledge about human diseases and novel therapies through translational research. Indeed, OSR can count on 4 Research Divisions, 4 Research Institutes including San Raffaele Telethon Institute for Gene Therapy, 3 Research Centers, 4 Clinical Research Centers and more than 50 Clinical Operative Units. OSR is recognized as a global authority in cell and gene therapies and is at the forefront of research in many other fields.

Universidad de Navarra

Pamplona, Spain

Beneficiary

UNAV is a non-profit private university with a Biomedicine campus comprised by the School of Medicine, Sciences, Pharmacy, the University Clinic of Navarra (CUN) and two research centres. CUN is a reference centre in Spain for several procedures, including Regenerative Medicine strategies. The Cellular Therapy Area vision is to deliver new frontline treatments through interdisciplinary research into basic disease mechanisms and the application of novel therapeutic approaches and technology. 

Lausanne University Hospital

Lausanne, Switzerland

Associated Partner

The Lausanne University Hospital (CHUV) is one of Switzerland’s five university hospitals. With 16 clinical and medico-technical departments and their numerous services, it is renowned for its academic achievements in health care, research and teaching. Its Department of oncology UNIL CHUV, home to the Lausanne branch of the Ludwig Institute for Cancer Research, has developed the “Human Integrated Tumor Immunology Discovery Engine” (Hi-TIDe), an innovative research structure working to create novel therapies based on the administration of genetically modified T cells to defeat tumors. The Hi-TIDe is part of the Center of excellence in cell therapy, an integrated environment within which novel immunotherapy technologies are transferred to patients, born of the partnership between the CHUV, the University of Lausanne (UNIL), the canton of Vaud and the Ludwig Institute.

 

Universitätsklinikum Freiburg

Freiburg, Germany

Beneficiary

The Medical Center – University of Freiburg is one of the most prestigious Medical Schools in Germany, engaging in research, teaching and healthcare as its core responsibilities. The Institute for Transfusion Medicine & Gene Therapy provides hemotherapies as well as transfusion and transplantation related diagnostic services. In research it focuses on developing safe ATMPs using genome. editing.

Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas

Madrid, Spain

Beneficiary

The mission of CIEMAT is to contribute to the sustainable development of the country and to the quality of life of citizens, through the generation, application and dissemination of scientific and technological knowledge, with special emphasis on applied research and development and technological demonstration.
The Biomedical Innovation Unit constitutes one of the six technical Departments of CIEMAT, and aims at the development of Innovative translational research to improve the diagnosis and treatment of a number of inherited and acquired pathologies through modern techniques of genetics and molecular and cellular biology.

Fundación Miguel Servet

Pamplona, Spain

Beneficiary

Navarrabiomed is a public biomedical research. Its mission is to promote, facilitate and perform leading-edge biomedical research to develop and implement innovative therapies that improve the quality of public healthcare. 18 research units, six technical and scientific services and 140 researchers. Navarrabiomed facilitates and promotes research carried out by 250 healthcare professionals.

Università Vita-Salute San Raffaele

Milan, Italy

Third party in kind contribution against payment

Since its establishment, the University has been characterized by a strong integration of teaching and research, in each of its facets: basic, philosophical and social. The mission of Vita-Salute San Raffaele is to answer to the question “What is the man” strongly believing that the human kind is biologically, psychologically and spiritually unique. It is a point of reference in the field of university education, as one of the top academic institutions in Italy.